Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women
NCT ID: NCT06909695
Last Updated: 2025-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
33 participants
OBSERVATIONAL
2024-11-01
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The overall goal of the present study is to characterize iron status and physiological responses (including but not limited to sweating, skin blood flow, ventilation, and heart rate) to extreme environmental stressors of heat, cold and high altitude (i.e. hypobaric hypoxia) in women utilizing LARCs. Up to thirty-three individuals (n=18 LARCs, n=15 monophasic oral contraceptives) will complete testing visits separated by at least 48 hours for environmental testing visits. During heat stress testing, measures of core body temperature, skin temperature, and sweat rate will be measured during a standardized protocol in hot, humid conditions. During cold stress, measures of body core temperature, metabolic heat production, skin blood flow and temperature (at both distal extremity and proximal body sites) will be assessed in order to better quantify the impact of exogenous sex hormones via LARCs and OCs in volunteers exposed to the cold. Measurements will be obtained during a standardized protocol in cold air (\~90 min; 10°C). For altitude, cardiopulmonary responses will be assessed during rest and exercise during an acute altitude exposure (4300m). Blood samples will be collected throughout the investigation in order to quantify sex hormone concentrations, iron status, and inflammatory biomarkers in response to environmental stressors. The investigators will also utilize laboratory tests (i.e., carbon monoxide (CO) rebreathing technique) and collect blood samples to quantity iron stores in these groups of women. To characterize iron status, the Soldier Performance Health and Readiness (SPHERE) epidemiological data repository will be utilized to quantify the prevalence of iron deficiency and iron deficient anemia diagnoses between women using LARCs and women not utilizing LARCs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Levonorgestrel Intrauterine System on Hemoglobin Level
NCT06935968
Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya
NCT05233956
Long-Acting Reversible Contraception
NCT01299116
Assessing Ovarian Function During Prolonged Implant Use
NCT03058978
The Effect of Birth Control Methods on Anti-Mullerian Hormone (AMH) Levels
NCT01308931
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SARC
Control group utilizing short-acting reversible contraceptives (i.e. combined oral contraceptives tested only in the active pill phase or transdermal patch)
Blood volume and environmental testing
Testing blood volume measures, iron stores, and physiological responses to acute environmental exposures of heat, cold, and high-altitude (each environment independently)
LARC users
Users of hormonal long-acting reversible contraceptives (LARCs) (e.g. hormonal IUDs, hormonal subcutaneous implants)
Blood volume and environmental testing
Testing blood volume measures, iron stores, and physiological responses to acute environmental exposures of heat, cold, and high-altitude (each environment independently)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood volume and environmental testing
Testing blood volume measures, iron stores, and physiological responses to acute environmental exposures of heat, cold, and high-altitude (each environment independently)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Females taking monophasic oral contraceptives or utilizing implantable contraception (intrauterine device, implantable bar) for at least one year, and be at least one year removed from the removal end point (e.g. before year 4 for a 5-year IUD)
* In good health as determined by OMSO (Office of Medical Support and Oversight)
* Passed most recent Army Combat Fitness Test (ACFT) (military volunteers only) or exercise at least 2 times per week (civilian volunteers)
* Willing to not drink alcoholic beverages for 24 hours before each testing session
* Willing to not consume caffeine 12 hours prior to any testing sessions
* Willing to refrain from any exercise and additional moderate to strenuous physical activity 24 hours prior to testing
* Willing to stay and exercise in an altitude chamber (the size of a dorm room) for \~6 hours
* Supervisor approval for federal civilian employees and non-HRV active-duty military personnel stationed at NSSC.
Exclusion Criteria
* Taking prescription, over the counter medication, or dietary supplements, other than a contraceptive (unless approved by OMSO and Principal Investigator (PI))
* Tobacco or nicotine users, or anyone who has used tobacco or nicotine within the last four months
* Physical problems/injuries (e.g., current stress fractures, musculoskeletal strains) that would affect walking or running on a treadmill
* Allergy to skin adhesive
* Heart, lung, kidney, muscle, endocrine, or nerve disorder(s) as determined by OMSO
* History of heat intolerance or orthostatic intolerance
* Diagnosed and/or treated for fluid/electrolyte imbalance within the last 30 days
* History of obstructive disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis.
* Scheduled MRI within 2 weeks after completing a heat or cold test
* Actively dieting with the intent to lose weight
* History of cold injuries of any severity (e.g., frostbite, trench foot, chilblains).
* Raynaud's syndrome
* Cold-induced asthma/bronchospasm
* Not willing to have small areas of skin on the body shaved (if deemed necessary for attachment of study instrumentation)
* Born at altitudes greater than 2,100 m (7,000 ft) (e.g., Mexico City, Mexico)
* Living in areas that are more than 1,200 m (4,000 ft) (e.g., Colorado Springs, CO) or have traveled to areas that are more than 1,200 m for five days or more within the last 2 months
* Prior diagnosis of High Altitude Pulmonary Edema (HAPE) or High Altitude Cerebral Edema (HACE)
* Abnormal blood count in accordance with OMSO - Normal Hb women: 11.1-15.9 g·dL-1 or Normal Hct women: 34.0-48%, or presence of abnormal blood chemicals (hemoglobin S or Sickle Cell Trait)
* History of pneumothorax
* History of hypertension
* Blood donation within 8 weeks of beginning the study
* Any recent (within 4-6 weeks) and or expected history of prolonged periods of immobility or limited activity (including recent or upcoming surgery)
* Evidence of apnea or sleeping disorder (narcolepsy, insomnia, etc.)
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Army Research Institute of Environmental Medicine
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gabrielle Giersch, PhD
Role: PRINCIPAL_INVESTIGATOR
United States Army Research Institute of Environmental Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
US Army Research Institute of Environmental Medicine
Natick, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.